MedTrace Logo

Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial

NCT02413268 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 2400

Last updated 2019-09-17

No results posted yet for this study

Summary

A randomized comparison of topical nitroglycerin versus placebo gel for prevention of radial artery occlusion after transradial catheterization.

Conditions

  • Total Atherosclerotic Occlusion of Radial Artery

Interventions

DRUG

Nitroglycerin

Sponsors & Collaborators

  • Total Cardiovascular Solutions

    lead OTHER

Principal Investigators

  • Tejas M Patel, MD · Apex Heart Institute, Ahmedabad, India

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2020-07-31
Completion
2020-07-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02413268 on ClinicalTrials.gov